The Supreme Court of the United States temporarily once again allowed the delivery of the abortion medication by mail
Washington, May 4, 2026 – The Supreme Court of the United States has temporarily reinstated a federal rule that permits the prescription of the abortion medication (mifepristone) via telemedicine and its delivery by mail. By this decision, the Court temporarily blocked the ruling of a lower instance that had restricted access to the medication on a nationwide scale.
“Administrative Stay” and details of the dispute
Justice Samuel Alito of the Supreme Court issued an interim order (the so-called Administrative Stay), thereby suspending the decision of the U.S. Court of Appeals for the Fifth Circuit in New Orleans. The appellate court, last Friday, granted the claim of the State of Louisiana and reinstated the previous federal regulation, which required a patient’s physical visit to a clinic in order to obtain the medication.
• Temporary nature: Justice Alito’s order remains in force until May 11. This provides the Court with additional time to consider the emergency applications of the medication manufacturers (Danco Laboratories and GenBioPro).
• Positions of the parties: The Chief Executive Officer of GenBioPro, Evan Masingill, welcomed the decision and noted that it will reduce the chaos experienced by patients and physicians. For her part, the Attorney General of Louisiana, Liz Murrill, emphasized the temporary nature of the order and expressed confidence that “the law will ultimately prevail.”
• Statistics: It is noteworthy that medication abortions performed using the combination of mifepristone and misoprostol currently account for more than 60% of all abortions in the United States.
Analysis by the lawyers of Kh & Partners
The present legal development is of critical importance both for the autonomy of federal agencies and for the future of telemedicine.
Legal assessment by our experts:
- Significance of the Administrative Stay: An administrative stay does not constitute a determination on the merits of the case. It is a procedural mechanism from the so-called “Shadow Docket,” which the Supreme Court employs to preserve the status quo and prevent irreparable harm (or legal chaos) until it has fully considered the arguments of the parties.
- Authority of the FDA vs. powers of the states: At the center of the dispute remains the question — whether an individual state (in this case, Louisiana) has the authority to alter or nullify scientifically grounded rules established by the Food and Drug Administration (FDA), including safety standards for telemedicine and mail distribution.
- Impact of the 2024 precedent: It should be recalled that in 2024 the Supreme Court had already rejected a claim by anti-abortion groups against mifepristone. At that time, the Court determined that the plaintiffs lacked the requisite legal standing. In the present case, the plaintiff is the state itself, which alters the legal dynamics; however, prior decisions of the Supreme Court indicate caution against intrusive interference in FDA regulations.
Conclusion of Kh & Partners: “The decision to be taken by May 11 will likely shape the regulatory landscape of telemedicine for the coming months. Although the issue is heavily politicized against the backdrop of the forthcoming congressional elections, this interim step by the Supreme Court indicates that abrupt invalidation of federal regulatory decisions by lower courts is not advisable for a stable legal practice.”
Why do clients trust us?
▪️ 33+ years of experience in the field of law
▪️ 160+ lawyers in the global network
▪️ 2000+ business customers and satisfied clients
▪️ 96% success rate and 100+ acquittals
▪️ ISO standard and highest quality of service
▪️ Insured legal services
🌍 International scale — our geography includes countries: Georgia, USA, France, Spain, Ukraine, Turkey, China, South Korea and others.
Our philosophy: Peace, Reliability and Victory!
Contact us today and let’s schedule a working meeting:
📞 +995 595 17 17 41
✉️ info@khlaws.com
📍 Tbilisi, Georgia
ანალიტიკა
